Stock market

Why NEC, CNI, OML hit their 52-week lows yesterday

ws. The Australian share market traded on a weak note on Tuesday and ended in the red, weighed down by tech, banks, and telecommunications. The...

ASX 200 to fall as Wall Street dips; all eyes on GDP data

Highlights The Australian share market is expected to fall once again on Wednesday. According to the latest SPI futures, the ASX 200 is li...

ASX 200 sheds 1.03% as tech, telco and banking stocks lead losses

DP numbers. After Monday’s glittery opening, the ASX 200 witnessed a quick turnaround today. The benchmark index dropped 1.03% to 7,211.20...

RIO, BHP, MIN: How are these ASX iron ore stocks performing today?

Highlights The iron ore futures price rose 0.1% to US$133.60 a tonne on Monday as China relaxed COVID-19 curbs. The rise in iron ore price seems t...

ASIA, CRYP, ESPO: How these 3 ASX tech ETFs have fared in past month

Highlights ETFs provide investors with an option to access many shares via a single investment. Rising inflation and interest rates have k...

Why BUB, AKE hit new 52-week highs yesterday

hs. The Australian share market ended on a strong note on Monday amid a broad market-rally. While the benchmark ASX 200 index rose 1.45%, the A...

ASX 200 to fall; oil soars; market awaits economic data

ay. The Australian share market is likely to inch lower on Tuesday after witnessing broad gains for two straight sessions, while global sentime...

ASX 200 ends 1.45% higher amid broad market rally, Tech stocks lead...

ASX200 has commenced the new week on an encouraging note, gaining 1.45% to close at 7,286.60 points on Monday. With today’s gains, the index has...

PLS, MIN, AKE: 3 ASX lithium shares to watch out for in June 2022

Highlights Lithium is extensively used in rechargeable batteries. The metal is now considered "the new gold". Many lithium stocks performed wel...

RIO, BHP, STO-how are these blue-chips performing today?

Highlights ASX200 closed 1.45% up on 30 May. The energy and material biggies like RIO, BHP and Santos also added to their pricing. The ASX200...

Here’s why Biome Australia (ASX:BIO) share price gained 10% today 

Shares of Biome Australia Limited (ASX:BIO) edged up by nearly 10% on Monday as the company announced an expansion of its distribution network in Aust...

A2M, BGA, AHF: Why are these dairy stocks in focus today

Highlights ASX-listed dairy stocks have risen on Bubs’ export deal with the US Government.  As a result, the stocks have garnered a lot...

SQ2, WTC, XRO, CPU: Why are these ASX tech stocks trading higher tod...

Highlights The benchmark index ASX 200 was up 1.048% to 7,258.00 points at 10:49 AM AEST today. The S&P/ASX 200 Information Technology Sector...

DRO, OEC, MOB: How did these 3 ASX drone stocks perform YTD?

Drones are becoming increasingly popular in Australia, which is regarded as a major player in the drone industry. Drone-friendly rules, plenty of deve...

ASX 200 gains over 1% as tech stocks jump; Bubs Australia soars 45%

The Australian share market started this week’s trade on a positive note, following strong cues from Wall Street. The benchmark index ASX 200 ga...

ASX 200 to rise, GDP data to guide market this week

er. The Australian share is expected to begin the week on a strong note following a robust closing on Wall Street last Friday. while higher iro...

ASX 200 closes 1.08% higher following strong lead on Wall Street 

cretionary. Closing the week above its 20-day Moving Average (MA), the ASX 200 posted a 1.08% gain today to close at 7,182.70. The Aussie be...

SYR, RNU, QGL: Look at the performance of these ASX Graphite stocks

Highlights Demand for Graphite is expected to grow to meet the demands of the rapidly expanding EV industry. China, Brazil, Mozambique, Russia, Ma...

GMG, LLC, DXS: How are these real estate stocks faring today on ASX?

With the global rise in construction costs, the construction sector has been facing a challenging situation since the onset of this year. After a few...

Race Oncology (ASX:RAC) shares jump on positive Zantrene AML trial r...

Highlights Race Oncology has received encouraging results from the first-stage trial of Zantrene in relapsed or refractory Acute Myeloid Leukaemi...